Structures of α-synuclein filaments from multiple system atrophy

被引:498
作者
Schweighauser, Manuel [1 ]
Shi, Yang [1 ]
Tarutani, Airi [2 ,3 ]
Kametani, Fuyuki [2 ]
Murzin, Alexey G. [1 ]
Ghetti, Bernardino [4 ]
Matsubara, Tomoyasu [5 ]
Tomita, Taisuke [3 ]
Ando, Takashi [6 ]
Hasegawa, Kazuko [7 ]
Murayama, Shigeo [5 ]
Yoshida, Mari [8 ]
Hasegawa, Masato [2 ]
Scheres, Sjors H. W. [1 ]
Goedert, Michel [1 ]
机构
[1] MRC Lab Mol Biol, Cambridge, England
[2] Tokyo Metropolitan Inst Med Sci, Dept Brain & Neurosci, Tokyo, Japan
[3] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan
[4] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[5] Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan
[6] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi, Japan
[7] Sagamihara Natl Hosp, Div Neurol, Sagamihara, Kanagawa, Japan
[8] Aichi Med Univ, Inst Med Sci Aging, Nagakute, Aichi, Japan
关键词
GLIAL CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; LEWY BODIES; OLIVOPONTOCEREBELLAR ATROPHY; PATHOGENIC FIBRIL; TAU; AGGREGATION; DEMENTIA; MUTATION; DEGENERATION;
D O I
10.1038/s41586-020-2317-6
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Synucleinopathies, which include multiple system atrophy (MSA), Parkinson's disease, Parkinson's disease with dementia and dementia with Lewy bodies (DLB), are human neurodegenerative diseases(1). Existing treatments are at best symptomatic. These diseases are characterized by the presence of, and believed to be caused by the formation of, filamentous inclusions of alpha-synuclein in brain cells(,)(2)(3). However, the structures of alpha-synuclein filaments from the human brain are unknown. Here, using cryo-electron microscopy, we show that alpha-synuclein inclusions from the brains of individuals with MSA are made of two types of filament, each of which consists of two different protofilaments. In each type of filament, non-proteinaceous molecules are present at the interface of the two protofilaments. Using two-dimensional class averaging, we show that alpha-synuclein filaments from the brains of individuals with MSA differ from those of individuals with DLB, which suggests that distinct conformers or strains characterize specific synucleinopathies. As is the case with tau assemblies(4-9), the structures of alpha-synuclein filaments extracted from the brains of individuals with MSA differ from those formed in vitro using recombinant proteins, which has implications for understanding the mechanisms of aggregate propagation and neurodegeneration in the human brain. These findings have diagnostic and potential therapeutic relevance, especially because of the unmet clinical need to be able to image filamentous alpha-synuclein inclusions in the human brain.
引用
收藏
页码:464 / +
页数:18
相关论文
共 70 条
[1]   PHENIX: a comprehensive Python']Python-based system for macromolecular structure solution [J].
Adams, Paul D. ;
Afonine, Pavel V. ;
Bunkoczi, Gabor ;
Chen, Vincent B. ;
Davis, Ian W. ;
Echols, Nathaniel ;
Headd, Jeffrey J. ;
Hung, Li-Wei ;
Kapral, Gary J. ;
Grosse-Kunstleve, Ralf W. ;
McCoy, Airlie J. ;
Moriarty, Nigel W. ;
Oeffner, Robert ;
Read, Randy J. ;
Richardson, David C. ;
Richardson, Jane S. ;
Terwilliger, Thomas C. ;
Zwart, Peter H. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :213-221
[2]   The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure [J].
Boyer, David R. ;
Li, Binsen ;
Sun, Chuanqi ;
Fan, Weijia ;
Zhou, Kang ;
Hughes, Michael P. ;
Sawaya, Michael R. ;
Jiang, Lin ;
Eisenberg, David S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (07) :3592-3602
[3]   Structures of fibrils formed by α-synuclein hereditary disease mutant H50Q reveal new polymorphs [J].
Boyer, David R. ;
Li, Binsen ;
Sun, Chuanqi ;
Fan, Weijia ;
Sawaya, Michael R. ;
Jiang, Lin ;
Eisenberg, David S. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2019, 26 (11) :1044-+
[4]   The solubility of α-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease [J].
Campbell, BCV ;
McLean, CA ;
Culvenor, JG ;
Gai, WP ;
Blumbergs, PC ;
Jäkälä, P ;
Beyreuther, K ;
Masters, CL ;
Li, QX .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) :87-96
[5]   MolProbity: all-atom structure validation for macromolecular crystallography [J].
Chen, Vincent B. ;
Arendall, W. Bryan, III ;
Headd, Jeffrey J. ;
Keedy, Daniel A. ;
Immormino, Robert M. ;
Kapral, Gary J. ;
Murray, Laura W. ;
Richardson, Jane S. ;
Richardson, David C. .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2010, 66 :12-21
[6]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[7]   Synthetic filaments assembled from C-terminally truncated α-synuclein [J].
Crowther, RA ;
Jakes, R ;
Spillantini, MG ;
Goedert, M .
FEBS LETTERS, 1998, 436 (03) :309-312
[8]   Stabilization of α-synuclein secondary structure upon binding to synthetic membranes [J].
Davidson, WS ;
Jonas, A ;
Clayton, DF ;
George, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (16) :9443-9449
[9]  
Dejerine J., 1900, Nouv Iconog de le Salpetriere, V13, P330
[10]   Features and development of Coot [J].
Emsley, P. ;
Lohkamp, B. ;
Scott, W. G. ;
Cowtan, K. .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2010, 66 :486-501